These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Boyd-Kimball D, Mohmmad Abdul H, Reed T, Sultana R, Butterfield DA. Chem Res Toxicol; 2004 Dec; 17(12):1743-9. PubMed ID: 15606152 [Abstract] [Full Text] [Related]
5. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide. Tõugu V, Karafin A, Palumaa P. J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347 [Abstract] [Full Text] [Related]
7. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease]. Manzano-León N, Mas-Oliva J. Gac Med Mex; 2006 Mar; 142(3):229-38. PubMed ID: 16875352 [Abstract] [Full Text] [Related]
8. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation. Johansson AS, Bergquist J, Volbracht C, Päiviö A, Leist M, Lannfelt L, Westlind-Danielsson A. Neuroreport; 2007 Apr 16; 18(6):559-63. PubMed ID: 17413657 [Abstract] [Full Text] [Related]
9. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. Decker H, Jürgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, Epstein AL, De Felice FG, Jerusalinsky D, Ferreira ST. J Neurochem; 2010 Dec 16; 115(6):1520-9. PubMed ID: 20950339 [Abstract] [Full Text] [Related]
10. Analysis of Abeta interactions using ProteinChip technology. Giannakis E, Hung LW, Camacaro KP, Smith DP, Barnham KJ, Wade JD. Methods Mol Biol; 2008 Dec 16; 494():71-86. PubMed ID: 18726569 [Abstract] [Full Text] [Related]
11. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems. Baruch-Suchodolsky R, Fischer B. Biochemistry; 2009 May 26; 48(20):4354-70. PubMed ID: 19320465 [Abstract] [Full Text] [Related]
12. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell. Clementi ME, Martorana GE, Pezzotti M, Giardina B, Misiti F. Int J Biochem Cell Biol; 2004 Oct 26; 36(10):2066-76. PubMed ID: 15203119 [Abstract] [Full Text] [Related]
13. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide. Han D, Wang H, Yang P. Biometals; 2008 Apr 26; 21(2):189-96. PubMed ID: 17629774 [Abstract] [Full Text] [Related]
14. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid. Kanapathipillai M, Lentzen G, Sierks M, Park CB. FEBS Lett; 2005 Aug 29; 579(21):4775-80. PubMed ID: 16098972 [Abstract] [Full Text] [Related]
15. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma. Mare S, Penugonda S, Robinson SM, Dohgu S, Banks WA, Ercal N. Peptides; 2007 Jul 29; 28(7):1424-32. PubMed ID: 17580097 [Abstract] [Full Text] [Related]
16. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrêne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V. Biochem J; 2009 Jul 15; 421(3):415-23. PubMed ID: 19435461 [Abstract] [Full Text] [Related]
17. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. Biochem Biophys Res Commun; 1994 Apr 29; 200(2):710-5. PubMed ID: 8179604 [Abstract] [Full Text] [Related]
18. The Cu(II)/Abeta/human serum albumin model of control mechanism for copper-related amyloid neurotoxicity. Rózga M, Bal W. Chem Res Toxicol; 2010 Feb 15; 23(2):298-308. PubMed ID: 19950960 [Abstract] [Full Text] [Related]
19. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. Meli G, Visintin M, Cannistraci I, Cattaneo A. J Mol Biol; 2009 Apr 03; 387(3):584-606. PubMed ID: 19361429 [Abstract] [Full Text] [Related]
20. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villà-Freixa J, Suzuki T, Fernàndez-Busquets X, Valverde MA, de Strooper B, Muñoz FJ. Brain; 2009 May 03; 132(Pt 5):1335-45. PubMed ID: 19251756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]